COMMUNIQUÉS West-GlobeNewswire

Organovo Appoints New Board Member
20/02/2019
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Sienna Biopharmaceuticals Prices Public Offering of Common Stock
20/02/2019
WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 8, [...]
Milestone Scientific Provides Update on CompuFlo® Epidural System Commercial Launch
20/02/2019
Four published studies validate instrument effectiveness in identifying epidural space More than 1,500 epidural procedures performed by key opinion leaders First hospital in Italy adopts CompuFlo for all epidurals in [...]
CareDx Drives Personalized Medicine in Transplantation at CEOT
20/02/2019
AlloSure highlighted at Cutting Edge in Transplantation conference in multiple sessions BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the [...]
miRagen Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results and Host a Conference Call on March 13th
20/02/2019
BOULDER, Colo., Feb. 20, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will [...]
Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
VBL Therapeutics Awarded $2.9 Million Non-Dilutive Grant by the Israel Innovation Authority
20/02/2019
TEL AVIV, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (the “Company”) today announced that it has been awarded a non-dilutive grant of over 10 million New Israeli Shekels (approximately $2. [...]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast
20/02/2019
NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]
Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
NEWARK, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Allogene Therapeutics Enters Lease to Build Manufacturing Facility to Develop and Commercialize Allogeneic CAR T (AlloCAR T™) Therapies
20/02/2019
State-of-the-Art Manufacturing Facility to be Located in the San Francisco East Bay Area Allogene Committed to Advanced Cell Manufacturing for Long-Term Clinical and Commercial AlloCAR T™ Production SOUTH SAN FRANCISCO [...]
BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific
20/02/2019
Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea JERUSALEM, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN) , a global leader in the advanced non- [...]
Fulgent Genetics to Announce Fourth Quarter and Full Year 2018 Financial Results on Thursday February 28, 2019
20/02/2019
TEMPLE CITY, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2018 financial [...]
Progressive Care Inc. Announces Best January in Company History
20/02/2019
MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations
20/02/2019
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 20, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
BioSig Announces Successful First-In-Human Use of PURE EP System
20/02/2019
Early Results Suggest Improved Cardiac Signal Detection and Fidelity Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary [...]
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
20/02/2019
Initial top line data of MS1819-SD in Cystic Fibrosis Patients expected in mid-2019. First patients dosed in open-label, cross-over Phase II OPTION study with MS1819-SD for exocrine pancreatic insufficiency in cystic [...]

Pages